Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid TumorsPankita H. Pandya, Karen E. Pollok, Asha Jacob Jannu et al.|Cancers|2022Cited by 14
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantationHan Yan, Sophie Paczesny, Khadijeh Bijangi‐Vishehsaraei et al.|JCI Insight|2023Cited by 7